anti-DC-ASGPR mAbs (Baylor Research Institute)

N/A

Report date: 2025/03/14 18:13:25

Base Information

Drug Nameanti-DC-ASGPR mAbs (Baylor Research Institute)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAsialoglycoprotein receptor antagonists
TargetsAsialoglycoprotein receptor
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaylor Research Institute Llc
China Registration ClassN/A

Develop Information

Active CompaniesBaylor Research Institute Llc
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A